Mode
Text Size
Log in / Sign up
Phase 3 N=120 Randomized Triple-blind Treatment

The Clinical Efficacy of Three Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste and a Mouthwash in Controlling Dental Plaque and Gingivitis

Dental Plaque · Gingivitis

Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcome: Primary: Dental Plaque Scores — 3.33; 3.19; 3.31 units on a scale — p=0.434

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
triclosan/fluoride toothpaste + cetylpyridinium chloride Mouthwash (Drug); stannous fluoride toothpaste + cetylpyridinium chloride Mouthwash (Drug); fluoride toothpaste + fluoride Mouthwash (Drug)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Colgate Palmolive
Primary completion
Aug 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Dental Plaque Scores
2.42; 2.59; 3.38 <0.001 sig
PRIMARY
Dental Plaque Scores
2.42; 2.59; 3.38 <0.001 sig
PRIMARY
Dental Plaque Scores
2.42; 2.59; 3.38 <0.001 sig
PRIMARY
Gingivitis Scores
1.03; 1.21; 1.46 <0.001 sig
PRIMARY
Gingivitis Scores
1.03; 1.21; 1.46 <0.001 sig
PRIMARY
Gingivitis Scores
1.03; 1.21; 1.46 <0.001 sig

Summary

The objective of this clinical research study is to assess the efficacy of three oral hygiene multi-component regimens encompassing the use of a manual toothbrush, toothpaste and a mouthwash in controlling established dental plaque and gingivitis.

Eligibility Criteria

Inclusion Criteria

  • Male and female subjects, ages 21-70, inclusive.
  • Availability for the six-week duration of the study.
  • Good general health.
  • Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
  • Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
  • Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).
  • Signed Informed Consent Form.

Exclusion Criteria

  • Presence of orthodontic bands.
  • Presence of partial removable dentures.
  • Tumor(s) of the soft or hard tissues of the oral cavity.
  • Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
  • Five or more carious lesions requiring immediate restorative treatment.
  • Use of antibiotics any time during the one month prior to entry into the study.
  • Participation in any other clinical study or test panel within the one month prior to entry into the study.
  • Pregnant women or women who are breast feeding.
  • Dental prophylaxis received in the past two weeks prior to baseline examinations.
  • History of allergies to oral care/personal care consumer products or their ingredients.
  • On any prescription medicines that might interfere with the study outcome.
  • An existing medical condition which prohibits eating or drinking for periods up to 4 hours.
  • History of alcohol or drug abuse
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02193165). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search